284
Edgewise Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
357
FY23:
327
FY24:
475
FY25:
543
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.46
FY22:
10.1
FY23:
13.0
FY24:
11.3
FY25:
9.22
Total assets
Change from FY21 to FY25
millions USD
FY21:
285
FY22:
367
FY23:
340
FY24:
487
FY25:
553
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.5
FY22:
16.6
FY23:
16.8
FY24:
23.9
FY25:
27.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.33
FY22:
3.80
FY23:
4.43
FY24:
3.74
FY25:
2.98
(positive)
Change from FY21 to FY25
millions USD
FY21:
274
FY22:
347
FY23:
319
FY24:
459
FY25:
522
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
285
FY22:
367
FY23:
340
FY24:
487
FY25:
553
All amounts in millions USD